SEC Form 4 · accession 0001209191-18-002575
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Fairey
Officer — Chief Operating Officer
Period of report
Jan 3, 2018
Accepted (ET)
Jan 5, 2018 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buyF2,F1 | $6.19 | Jan 3, 2018 | A | 575,000 | A | — | Jan 3, 2028 | Common Stock | 575,000 | 575,000 | D |
Explanation of responses
- F1The option was granted on January 3, 2018. 25% of the total number of shares of common stock subject to the option will vest on January 3, 2019, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- F2Not applicable.